- Filed
- Mar 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 27, 2025 | 17.01M sh |
| Cost Of Revenue | FY 2024 · Jan 31, 2025 | $551.01M |
| Cost Of Revenue | FY 2024 · Jan 31, 2024 | $735.17M |
| Cost Of Revenue | FY 2024 · Jan 31, 2023 | $806.4M |
| Short Term Investments | FY 2024 · Jan 31, 2024 | $155.26M |
| Cash And Equivalents | FY 2024 · Jan 31, 2024 | $223.4M |
| Cash And Equivalents | FY 2024 · Jan 31, 2023 | $69.61M |
| Stockholders Equity | FY 2024 · Jan 31, 2024 | $513.92M |
| Current Liabilities | FY 2024 · Jan 31, 2024 | $66.26M |
| Current Assets | FY 2024 · Jan 31, 2024 | $452.1M |
| Total Assets | FY 2024 · Jan 31, 2024 | $664.8M |
| Shares Diluted | FY 2024 · Jan 31, 2023 | 17.64M sh |
| Stock Repurchased | FY 2024 · Jan 31, 2023 | $13.01M |
| Capex | FY 2024 · Jan 31, 2023 | $15.58M |
| Operating Cash Flow | FY 2024 · Jan 31, 2023 | $54.8M |
| Eps Diluted | FY 2024 · Jan 31, 2023 | $1.57 |
| Eps Basic | FY 2024 · Jan 31, 2023 | $1.57 |
| Sga Expense restated | FY 2024 · Jan 31, 2023 | $22.83M |
| Gross Profit restated | FY 2024 · Jan 31, 2023 | $48.6M |